health
An obesity drug deep-dive, and peptides move mainstream
Why this matters: health reporting relevant to everyday decisions and well-being.
Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow…
Read full story on STAT News → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop